Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael R Loebinger

Showing results (81-90 of 149) with videos related to

Pageof 15
Sort By:
American Journal of Respiratory and Critical Care Medicine|February 25, 2026
The CFTR potentiator Icenticaftor for treatment of bronchiectasis: An international phase 2, double-blind, randomized placebo-controlled trialWei-Jie Guan, Charles S Haworth, Harm A W M Tiddens, et al.
Respiratory Medicine|December 5, 2018
Quality control for multiple breath washout tests in multicentre bronchiectasis studies: Experiences from the BRONCH-UK clinimetrics studyKatherine O'Neill, Gokul R Lakshmipathy, Kathryn Ferguson, et al.
ERJ Open Research|May 26, 2022
ERS International Congress 2021: highlights from the Respiratory Infections AssemblyOliver W Meldrum, Kylie B R Belchamber, Kiarina D Chichirelo-Konstantynovych, et al.
The European Respiratory Journal|February 23, 2018
Primary ciliary dyskinesia with normal ultrastructure: three-dimensional tomography detects absence of DNAH11Amelia Shoemark, Thomas Burgoyne, Robert Kwan, et al.
Thorax|October 22, 2017
British Thoracic Society guidelines for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD)Charles S Haworth, John Banks, Toby Capstick, et al.
BMJ Open Respiratory Research|February 17, 2018
British Thoracic Society Guideline for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD)Charles S Haworth, John Banks, Toby Capstick, et al.
Annals of the American Thoracic Society|December 22, 2022
Clinimetric Properties of Outcome Measures in BronchiectasisJudy M Bradley, Kathryn Ferguson, Andrew Bailey, et al.
Chest|November 4, 2024
Clinical Efficacy of Serum Antiglycopeptidolipid Core IgA Antibody Test for Screening Nontuberculous Mycobacterial Pulmonary Disease in Bronchiectasis: A European Multicenter Cohort StudyHayoung Choi, Chloe Hughes, Zsofia Eke, et al.
Clinical Medicine (London, England)|February 22, 2024
Non-tuberculous mycobacterial pulmonary disease (NTM-PD): Epidemiology, diagnosis and multidisciplinary managementKartik Kumar, Aravind Ponnuswamy, Toby Gd Capstick, et al.
The European Respiratory Journal|June 29, 2023
Transforming clinical research and science in bronchiectasis: EMBARC3, a European Respiratory Society Clinical Research CollaborationJames D Chalmers, Stefano Aliberti, Josje Altenburg, et al.
Pageof 15

Showing results (81-90 of 149) with videos related to

Sort By:
Pageof 15
American Journal of Respiratory and Critical Care Medicine|February 25, 2026
The CFTR potentiator Icenticaftor for treatment of bronchiectasis: An international phase 2, double-blind, randomized placebo-controlled trialWei-Jie Guan, Charles S Haworth, Harm A W M Tiddens, et al.
Respiratory Medicine|December 5, 2018
Quality control for multiple breath washout tests in multicentre bronchiectasis studies: Experiences from the BRONCH-UK clinimetrics studyKatherine O'Neill, Gokul R Lakshmipathy, Kathryn Ferguson, et al.
ERJ Open Research|May 26, 2022
ERS International Congress 2021: highlights from the Respiratory Infections AssemblyOliver W Meldrum, Kylie B R Belchamber, Kiarina D Chichirelo-Konstantynovych, et al.
The European Respiratory Journal|February 23, 2018
Primary ciliary dyskinesia with normal ultrastructure: three-dimensional tomography detects absence of DNAH11Amelia Shoemark, Thomas Burgoyne, Robert Kwan, et al.
Thorax|October 22, 2017
British Thoracic Society guidelines for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD)Charles S Haworth, John Banks, Toby Capstick, et al.
BMJ Open Respiratory Research|February 17, 2018
British Thoracic Society Guideline for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD)Charles S Haworth, John Banks, Toby Capstick, et al.
Annals of the American Thoracic Society|December 22, 2022
Clinimetric Properties of Outcome Measures in BronchiectasisJudy M Bradley, Kathryn Ferguson, Andrew Bailey, et al.
Chest|November 4, 2024
Clinical Efficacy of Serum Antiglycopeptidolipid Core IgA Antibody Test for Screening Nontuberculous Mycobacterial Pulmonary Disease in Bronchiectasis: A European Multicenter Cohort StudyHayoung Choi, Chloe Hughes, Zsofia Eke, et al.
Clinical Medicine (London, England)|February 22, 2024
Non-tuberculous mycobacterial pulmonary disease (NTM-PD): Epidemiology, diagnosis and multidisciplinary managementKartik Kumar, Aravind Ponnuswamy, Toby Gd Capstick, et al.
The European Respiratory Journal|June 29, 2023
Transforming clinical research and science in bronchiectasis: EMBARC3, a European Respiratory Society Clinical Research CollaborationJames D Chalmers, Stefano Aliberti, Josje Altenburg, et al.
Pageof 15